Production of geranyl diphosphate-derived compounds

Patent metadata

Field	Value
Publication number	US-12529077-B2
Application number	US-202117917244-A
Country	US
Kind code	B2
Filing date	Apr 7, 2021
Priority date	Apr 8, 2020
Publication date	Jan 20, 2026
Grant date	Jan 20, 2026

Abstract

Disclosed is yeast cells having peroxisomally localized GPP synthase and a peroxisomally localized enzyme that converts GPP into a monoterpenoids, cannabinoids, monoterpene indole alkaloids and prenylated aromatic compounds; or a precursor therefore, which yeast cells are capable of producing improved amounts of monoterpenoids, cannabinoids, monoterpene indole alkaloids and prenylated aromatic compounds, compared with the same yeast cells where the GPP synthase and the enzyme that converts GPP are located in the cytoplasm. Further disclosed is the use of the yeast cell for producing monoterpenoids, cannabinoids, monoterpene indole alkaloids and prenylated aromatic compounds.

First claim

The invention claimed is:

1 . A recombinant host cell comprising,
a peroxisomally-localized enzyme catalyzing the formation of a branch point compound, which branch point compound can be converted in a prioritized pathway and in a non-prioritized pathway, wherein the enzyme catalyzing the formation of a branch point compound is a GPP synthase; and a peroxisomally-localized enzyme catalyzing the first step of the non-prioritized pathway, wherein the enzyme catalyzing the first step of the non-prioritized pathway is selected among a terpene synthase, a prenyltransferase, or another isoprenoid or non-isoprenoid prenyltransferase; and wherein the cell is capable of producing monoterpenoids, cannabinoids, iridoids, monoterpene indole alkaloids, and/or prenylated aromatic compounds at a level that is at least two-fold higher compared to a cell having the enzyme catalyzing the formation of the branch point compound and the enzyme catalyzing the first step of the non-prioritized pathway localized in the cytosol.

2 . The recombinant host cell of claim 1 , wherein the host cell is a yeast cell.

3 . The recombinant host cell of claim 2 , wherein the host cell is a yeast cell belonging to one of the genera: Saccharomyces, Pichia, Candida, Ogatea, or Yarrowia.

4 . The recombinant host cell of claim 3 , wherein the yeast is selected among the species: Saccharomyces cerevisiae, Pichia pastoris, Candida albicans, Candida boidinii, Ogatea polymorpha, or Yarrowia lipolytica.

5 . The recombinant host cell of claim 1 , wherein peroxisomal localization is provided by inserting a peroxisomal localization signal in the genes encoding the respective enzymes.

6 . The recombinant host cell of claim 1 , wherein the second enzyme is (+)-limonene synthase, (−)-limonene synthase, alpha-pinene synthase, 1,8-cineole synthase, sabinene synthase, camphene synthase, or geraniol synthase, beta-pinene synthase, linalool synthase, myrcene synthase, bornyl diphosphate synthase, alpha-terpineol synthase, isoborneol synthase, tricyclene synthase, alpha-thujene synthase, alpha-fenchene synthase, delta-2-carene synthase, alpha-phellandrene synthase, 3-carene synthase, 1,4-cineole synthase, alpha-terpinene synthase, beta-phellandrene synthase, (Z)-beta-ocimene synthase, (E)-beta-ocimene synthase, gamma-terpinene synthase, terpinolene synthase, allo-ocimene synthase, cis-beta-terpineol synthase, cis-terpine-1-ol synthase, delta-terpineol synthase, borneol synthase, alpha-terpineol synthase, nerol synthase, 2-methylisoborneol synthase, 2-methylenebornene synthase, 2-methyl-2-bornene synthase, or beta-phellandrene synthase.

7 . The recombinant host cell of claim 1 , wherein the second enzyme is capable of accepting non-canonical isoprenoid substrates with 9, 11, or 12 carbon atoms.

8 . The recombinant host cell of claim 1 , wherein the second enzyme is selected among an aromatic prenyltransferase and geranyldiphosphate: olivetolate geranyltransferase.

9 . The recombinant host cell of to claim 1 , wherein the enzyme catalyzing the formation of the branch point compound, and the enzyme catalyzing the first step of the non-prioritized pathway are selected among:
(a) an enzyme capable ofable to synthesize DMAPP, and an enzyme with isoprene synthase activity; (b) an enzyme capable ofable to synthesize DMAPP, and an enzyme with prenyltransferase activity similar to lavandulyl diphosphate synthase from Lavandula x intermedia or chrysanthemyl diphosphate synthase from Tanacetum cinerariifolium; (c) an enzyme capable of synthesize DMAPP, and an enzyme with C-prenyltransferase activity similar to 7-DMATS or AcPT1 from Artemisia capillaris ; or (d) an enzyme capable of synthesize DMAPP, and an enzyme with O-prenyltransferase activity similar to AcaPT from Antrodia camphorata.

10 . The recombinant host cell of claim 9 , wherein:
(a) the enzyme capable of synthesize DMAPP is isopentenyl diphosphate isomerase (IDI); (b) the enzyme with prenyltransferase activity is lavandulyl diphosphate synthase from Lavandula x intermedia or chrysanthemyl diphosphate synthase from Tanacetum cinerariifolium; (c) the enzyme with C-prenyltransferase activity is 7-DMATS or AcPT1 from Artemisia capillaris ; or (d) the enzyme with O-prenyltransferase activity is AcaPT from Antrodia camphorata.

11 . A method for producing a compound selected from the group consisting of: a monoterpenoid, a cannabinoid, a monoterpene indole alkaloid, and a prenylated aromatic compound, comprising the steps of:
a. providing a host cell according to claim 1 ; b. fermenting the host cell in a substrate supporting growth of the host cell; C. when required, providing the host cell with the substrate to be prenylated, and d. recovering the compound from the fermentation broth.

12 . The method of claim 11 , wherein the substrate to be prenylated is selected from the group consisting of: olivetolic acid, olivetolic acid derivatives, and p-coumaric acid.

13 . The method of claim 11 , further comprising the step of:
e. converting the compound of step d. to more complex products within the yeast cells by the action of additional native or heterologously expressed enzymes.

14 . The method of claim 11 , wherein the compound is selected from the group consisting of: sabinene, alpha-pinene, beta-pinene, camphene, (+)-limonene, (−)-limonene, geraniol, linalool, myrcene, 1,8-cineole, borneol, bornyl diphosphate, alpha-terpineol, isoborneol, tricyclene, alpha-thujene, alpha-fenchene, delta-2-carene, alpha-phellandrene, 3-carene, 1,4-cineole, alpha-terpinene, beta-phellandrene, (Z)-beta-ocimene, (E)-beta-ocimene, gamma-terpinene, terpinen-4-ol, terpinolene, allo-ocimene, cis-beta-terpineol, cis-terpine-1-ol, delta-terpineol, alpha-terpineol, nerol, 2-methylisoborneol, 2-methylenebornene, 2-methyl-2-bornene, beta-phellandrene, 2-methyllimonene, 2-methylmyrcene, 2-methylgeraniol, 2-methylinalool, cannabigerolic acid, cannabiberolic acid analogs, prenyl tryptophan, artepillin C, drupanin, osthrutin, geranyl-resveratrol, geranylated quercetin, geranyl-naringenin, geranyl-isoliqiritigenin, isobavachalcone, isoprene, lavandulol, chrysanthemol dimethylallyltryptophan, 4′-dimethylallyl-apigenin, 6-prenyl-apigenin, 4′-dimethylallyl-naringenin, 4′-dimethylallyl-kaempferol, 4′-dimethylallyl-daidzein, 7-dimethylallyl-daidzein, 7,4′-di-(dimethylallyl)-daidzein, 4′-dimethylallyl-genistein, 7-dimethylallyl-genistein, 7,4′-di-(dimethylallyl)-genistein, 4-dimethylallyl-isoliquiritigenin, 4′-dimethylallyl-equol, 7-dimethylallyl-equol, 6-dimethylallyl-equol, 4′-dimethylallyl-daidzin, 7-dimethylallyl-umbelliferone, 8-dimethylallyl- curcumin, 8′-dimethylallyl-demethoxycurcumin, 8-dimethylallyl-demethoxycurcumin, 4′-dimethylallyl-resveratrol, and 5 -dimethylallyl-diethylstilbestrol.

15 . A recombinant yeast host cell comprising,
a peroxisomally-localized enzyme catalyzing the formation of a branch point compound, which branch point compound can be converted in a prioritized pathway and in a non-prioritized pathway, wherein the enzyme catalyzing the formation of a branch point compound is a GPP synthase; and a peroxisomally-localized enzyme catalyzing the first step of the non-prioritized pathway, wherein the enzyme catalyzing the first step of the non-prioritized pathway is a terpene synthase selected from the group consisting of: geraniol synthase, linalool synthase, and myrcene synthase; and wherein the cell is capable of producing monoterpenoids, cannabinoids, iridoids, monoterpene indole alkaloids, and/or prenylated aromatic compounds at a level that is at least two-fold higher

Assignees

• Kobenhavns Univ
• Univ Copenhagen

Inventors

• Kampranis Sotirios
• Dusseaux Simon
• Ignea Codruta
• Wajn William Thomas

Classifications

• C12Y402/03

  acting on phosphates (4.2.3) · CPC title

• C12Y205/01029

  Geranylgeranyl diphosphate synthase (2.5.1.29) · CPC title

• C12P5/007

  containing one or more isoprene units, i.e. terpenes (carotenes C12P23/00) · CPC title

• C12N9/88

  Lyases (4.) · CPC title

• C12N9/1085 Primary

  transferring alkyl or aryl groups other than methyl groups (2.5) · CPC title